Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection

Ubiquitin-like protein ISG15 (interferon-stimulated gene 15) (ISG15) is a ubiquitin-like modifier induced during infections and involved in host defense mechanisms. Not surprisingly, many viruses encode deISGylating activities to antagonize its effect. Here we show that infection by Zika, SARS-CoV-2 and influenza viruses induce ISG15-modifying enzymes. While influenza and Zika viruses induce ISGylation, SARS-CoV-2 triggers deISGylation instead to generate free ISG15. The ratio of free versus conjugated ISG15 driven by the papain-like protease (PLpro) enzyme of SARS-CoV-2 correlates with macrophage polarization toward a pro-inflammatory phenotype and attenuated antigen presentation. In vitro characterization of purified wild-type and mutant PLpro revealed its strong deISGylating over deubiquitylating activity. Quantitative proteomic analyses of PLpro substrates and secretome from SARS-CoV-2-infected macrophages revealed several glycolytic enzymes previously implicated in the expression of inflammatory genes and pro-inflammatory cytokines, respectively. Collectively, our results indicate that altered free versus conjugated ISG15 dysregulates macrophage responses and probably contributes to the cytokine storms triggered by SARS-CoV-2.

[1]  M. Kumari,et al.  IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis. , 2021, The Journal of clinical investigation.

[2]  Andreas C. Damianou,et al.  Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity , 2020, British Journal of Cancer.

[3]  Ming Yuan Li,et al.  Lyn kinase regulates egress of flaviviruses in autophagosome-derived organelles , 2020, Nature Communications.

[4]  G. Hummer,et al.  Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity , 2020, Nature.

[5]  D. Lenschow,et al.  Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins , 2020, Cell Reports.

[6]  L. Cosmi,et al.  Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. , 2020, The Journal of clinical investigation.

[7]  Malik Peiris,et al.  Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures , 2020, The Lancet Respiratory Medicine.

[8]  Jianmin Li,et al.  Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing , 2020, Cell Discovery.

[9]  M. Tay,et al.  The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.

[10]  D. McGonagle,et al.  The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease , 2020, Autoimmunity Reviews.

[11]  D. McGonagle,et al.  The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease , 2020, Autoimmunity Reviews.

[12]  Ying Li,et al.  A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion , 2020, Cell.

[13]  Hongyang Wang,et al.  Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing , 2020, Cell Discovery.

[14]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[15]  L. Poon,et al.  Tropism of the Novel Coronavirus SARS-CoV-2 in Human Respiratory Tract: An Analysis in Ex Vivo and In Vitro Cultures , 2020, SSRN Electronic Journal.

[16]  K. Knobeloch,et al.  Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming , 2020, Science Advances.

[17]  Hector H. Huang,et al.  The LC3-Conjugation Machinery Specifies the Loading of RNA-Binding Proteins into Extracellular Vesicles , 2019, Nature Cell Biology.

[18]  Qin Ning,et al.  Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .

[19]  K. Knobeloch,et al.  Faculty Opinions recommendation of The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[20]  Thi H. O. Nguyen,et al.  Downregulation of MHC Class I Expression by Influenza A and B Viruses , 2019, Front. Immunol..

[21]  L. Poon,et al.  OTUB1 is a key regulator of RIG-I dependent immune signalling and is targeted for proteasomal degradation by influenza A NS1 , 2019, bioRxiv.

[22]  Moore Ar,et al.  'In sickness and health'. , 1979, Australian family physician.

[23]  D. Lenschow,et al.  ISG15 in antiviral immunity and beyond , 2018, Nature Reviews Microbiology.

[24]  Jeffrey S. Miller,et al.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control. , 2017, JCI insight.

[25]  J. Huibregtse,et al.  Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor. , 2017, Molecular cell.

[26]  The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage , 2017, Scientific Reports.

[27]  Colleen B. Jonsson,et al.  A Role for Neutrophils in Viral Respiratory Disease , 2017, Front. Immunol..

[28]  S. Perlman,et al.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.

[29]  C. Johansson,et al.  Type I Interferons as Regulators of Lung Inflammation , 2017, Front. Immunol..

[30]  D. Bogunovic,et al.  ISG15: In Sickness and in Health. , 2017, Trends in immunology.

[31]  D. Mansur,et al.  Beyond ISGlylation: Functions of Free Intracellular and Extracellular ISG15. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[32]  J. Izopet,et al.  ZIKA virus reveals broad tissue and cell tropism during the first trimester of pregnancy , 2016, Scientific Reports.

[33]  Y. Kong,et al.  Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification , 2016, Nature Communications.

[34]  David K. Meyerholz,et al.  Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice , 2016, Cell Host & Microbe.

[35]  D. Weiner,et al.  Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  K. Knobeloch,et al.  ISG15 counteracts Listeria monocytogenes infection , 2015, eLife.

[37]  Paul G. Thomas,et al.  Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells , 2015, Nature Communications.

[38]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[39]  Marisa Ponpuak,et al.  Secretory autophagy. , 2015, Current opinion in cell biology.

[40]  J. Casanova,et al.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation , 2014, Nature.

[41]  D. Lenschow,et al.  Novel Mode of ISG15-Mediated Protection against Influenza A Virus and Sendai Virus in Mice , 2014, Journal of Virology.

[42]  Sophia Davidson,et al.  Pathogenic potential of interferon αβ in acute influenza infection , 2014, Nature Communications.

[43]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[44]  T. Kuiken,et al.  Pathogenesis of influenza-induced acute respiratory distress syndrome. , 2014, The Lancet. Infectious diseases.

[45]  Sumana Sanyal,et al.  Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. , 2013, Cell host & microbe.

[46]  K. Knobeloch,et al.  ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection , 2013, PLoS pathogens.

[47]  J. Casanova,et al.  Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency , 2012, Science.

[48]  A. Halayko,et al.  Response of Primary Human Airway Epithelial Cells to Influenza Infection: A Quantitative Proteomic Study , 2012, Journal of proteome research.

[49]  Yoko Ito,et al.  Innate Immune Response of Human Alveolar Macrophages during Influenza A Infection , 2012, PloS one.

[50]  Adolfo García-Sastre,et al.  Induction and evasion of type I interferon responses by influenza viruses. , 2011, Virus research.

[51]  N. Baumgarth,et al.  Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity. , 2011, Future virology.

[52]  M. Chan,et al.  Viral Replication and Innate Host Responses in Primary Human Alveolar Epithelial Cells and Alveolar Macrophages Infected with Influenza H5N1 and H1N1 Viruses , 2011, Journal of Virology.

[53]  M. Tate,et al.  The Role of Neutrophils during Mild and Severe Influenza Virus Infections of Mice , 2011, PloS one.

[54]  Dong-er Zhang,et al.  Interferon-stimulated gene 15 and the protein ISGylation system. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[55]  Bali Pulendran,et al.  Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus , 2010, Proceedings of the National Academy of Sciences.

[56]  V. Chow,et al.  MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. , 2010, American journal of respiratory cell and molecular biology.

[57]  M. Tate,et al.  Critical Role of Airway Macrophages in Modulating Disease Severity during Influenza Virus Infection of Mice , 2010, Journal of Virology.

[58]  Hualan Chen,et al.  Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein , 2010, The Journal of Immunology.

[59]  Rei-Lin Kuo,et al.  ISG15 conjugation system targets the viral NS1 protein in influenza A virus–infected cells , 2010, Proceedings of the National Academy of Sciences.

[60]  S. Amini,et al.  Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[61]  R. Krug,et al.  Interferon-Induced ISG15 Conjugation Inhibits Influenza A Virus Gene Expression and Replication in Human Cells , 2009, Journal of Virology.

[62]  Scott A. Brown,et al.  TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection , 2009, Proceedings of the National Academy of Sciences.

[63]  J. Taubenberger,et al.  The pathology of influenza virus infections. , 2008, Annual review of pathology.

[64]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[65]  N. Sze,et al.  HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Y. Lau,et al.  Differential Expression of Chemokines and Their Receptors in Adult and Neonatal Macrophages Infected with Human or Avian Influenza Viruses , 2006, The Journal of infectious diseases.

[67]  E. Borden,et al.  Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. , 2005, Biochemical and biophysical research communications.

[68]  H. Klenk,et al.  Human and avian influenza viruses target different cell types in cultures of human airway epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Isamu Mori,et al.  Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. , 2004, The Journal of general virology.

[70]  S. Sung,et al.  Significant Involvement of CCL2 (MCP‐1) in Inflammatory Disorders of the Lung , 2003, Microcirculation.

[71]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[72]  U. Certa,et al.  Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. , 2002, Cancer research.

[73]  Emma J. Blott,et al.  Secretory lysosomes , 2002, Nature Reviews Molecular Cell Biology.

[74]  H. Fujisawa.  Inhibitory Role of Neutrophils on Influenza Virus Multiplication in the Lungs of Mice , 2001, Microbiology and immunology.

[75]  A. Haas,et al.  Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. , 1987, The Journal of biological chemistry.

[76]  P. Lengyel,et al.  Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells , 1979, Nature.